<p>在查看 Max Healthcare Institute（NSE:MAXHEALTH）最近的表現後，很難感到興奮，因為其股票在過去一個月中下跌了 2.0%。然而，股票價格通常是由公司的長期財務表現驅動的，而在這種情況下，前景看起來相當樂觀。具體來説，我們決定在本文中研究 Max Healthcare Institute 的股本回報率（ROE）。</p>
<p>股本回報率（ROE）是評估公司管理層如何有效利用公司資本的關鍵指標。簡而言之，ROE 顯示了每一美元的股東投資所產生的利潤。</p>
<p>我們發現 21 只美國股票預計明年將支付超過 6% 的股息收益率。查看完整列表，免費獲取。</p>
<h2>如何計算股本回報率？</h2>
<p><strong>股本回報率的公式是：</strong></p>
<p>股本回報率 = 淨利潤（來自持續經營）÷ 股東權益</p>
<p>因此，根據上述公式，Max Healthcare Institute 的 ROE 為：</p>
<p>13% = ₹14b ÷ ₹101b（基於截至 2025 年 9 月的過去十二個月）。</p>
<p>“回報” 指的是公司在過去一年的收益。換句話説，對於每₹1 的股本，公司能夠賺取₹0.13 的利潤。</p>
<p>查看我們對 Max Healthcare Institute 的最新分析</p>
<h2>ROE 與盈利增長有什麼關係？</h2>
<p>我們已經確定 ROE 作為公司未來盈利的有效利潤生成指標。根據公司選擇再投資或 “保留” 的利潤比例，我們能夠評估公司未來產生利潤的能力。假設其他條件相同，具有更高股本回報率和更高利潤保留的公司通常與沒有相同特徵的公司相比，具有更高的增長率。</p>
<h2>Max Healthcare Institute 的盈利增長與 13% ROE 的並排比較</h2>
<p>乍一看，Max Healthcare Institute 的 ROE 似乎並不那麼吸引人。然而，值得注意的是，該公司的 ROE 高於行業平均 ROE 的 11%。尤其是考慮到 Max Healthcare Institute 在過去五年中實現了 33% 的淨收入增長。這意味着該公司的 ROE 雖然起初略低，但仍高於行業平均水平。因此，盈利增長可能還有其他原因，比如高盈利保留率或公司屬於高增長行業。</p>
<p>接下來，與行業淨收入增長進行比較，我們發現 Max Healthcare Institute 的增長在同一時期內相較於行業平均增長 25% 相當高，這令人欣慰。</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/22615821-past-earnings-growth-1-dark-2/1767495947130?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/22615821-past-earnings-growth-1-dark-2/1767495947130"/></p>
<p>NSEI:MAXHEALTH 過去的盈利增長 2026 年 1 月 4 日</p>
<p>盈利增長是股票估值的一個重要因素。投資者接下來需要確定預期的盈利增長或缺乏盈利增長是否已經反映在股價中。通過這樣做，他們將能夠判斷股票是朝着清澈的水域前進，還是等待着泥濘的水域。如果你對 Max Healthcare Institute 的估值感到好奇，可以查看其市盈率與行業的比較。</p>
<h2>Max Healthcare Institute 是否有效利用其利潤？</h2>
<p>Max Healthcare Institute 的三年中位數派息比率較低，為 14%，這意味着它保留了更高比例（86%）的利潤。這表明管理層正在將大部分利潤再投資於業務增長，這從公司的增長中得到了證明。</p>
<p>儘管 Max Healthcare Institute 的盈利有所增長，但它最近才開始支付股息。公司很可能是為了給新老股東留下深刻印象而決定支付股息。現有分析師的估計表明，該公司的未來派息比率預計將在未來三年內降至 8.1%。與此同時，該公司的 ROE 預計將在同一時期內上升至 18%，這與派息比率的下降有關。</p>
<h2>總結</h2>
<p>總體而言，我們對 Max Healthcare Institute 的表現感到相當滿意。特別是看到公司在可觀的 ROE 和高再投資率的支持下實現了顯著的盈利增長，這令人振奮。儘管如此，最新的行業分析師預測顯示，該公司的盈利增長預計將放緩。要了解更多關於公司未來盈利增長預測的信息，請查看這份關於公司分析師預測的 <strong>免費</strong> 報告。</p>
<p>用於國防和災難的移動基礎設施</p>
<p>下一波機器人技術不是類人型的。它是完全自主的塔，在 30 分鐘內提供 5G、ISR 和雷達，隨時隨地。</p>
<p>在下一輪合同之前獲取投資者簡報</p>
<p>由 CiTech 贊助</p>

<p>Max Healthcare Institute 的股票最近下跌了 2.0%，儘管其財務前景強勁，顯示出 13% 的股本回報率（ROE）和五年內 33% 的淨收入增長，均超過行業平均水平。該公司保留了 86% 的利潤用於再投資，表明其對收益的有效利用。分析師預測未來的派息比率將降至 8.1%，ROE 將增加至 18%。然而，預計盈利增長將放緩，這引發了對該股票估值和未來表現的質疑</p>

<p>It is hard to get excited after looking at Max Healthcare Institute's (NSE:MAXHEALTH) recent performance, when its stock has declined 2.0% over the past month. However, stock prices are usually driven by a company’s financial performance over the long term, which in this case looks quite promising. Specifically, we decided to study Max Healthcare Institute's ROE in this article.</p>
<div class="lb-trans"><p>在查看 Max Healthcare Institute（NSE:MAXHEALTH）最近的表現後，很難感到興奮，因為其股票在過去一個月中下跌了 2.0%。然而，股票價格通常是由公司的長期財務表現驅動的，而在這種情況下，前景看起來相當樂觀。具體來説，我們決定在本文中研究 Max Healthcare Institute 的股本回報率（ROE）。</p>
</div><p>Return on equity or ROE is a key measure used to assess how efficiently a company's management is utilizing the company's capital. In short, ROE shows the profit each dollar generates with respect to its shareholder investments.</p>
<div class="lb-trans"><p>股本回報率（ROE）是評估公司管理層如何有效利用公司資本的關鍵指標。簡而言之，ROE 顯示了每一美元的股東投資所產生的利潤。</p>
</div><p>We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.</p>
<div class="lb-trans"><p>我們發現 21 只美國股票預計明年將支付超過 6% 的股息收益率。查看完整列表，免費獲取。</p>
</div><h2>How Do You Calculate Return On Equity?</h2>
<div class="lb-trans"><h2>如何計算股本回報率？</h2>
</div><p>The <strong>formula for return on equity</strong> is:</p>
<div class="lb-trans"><p><strong>股本回報率的公式是：</strong></p>
</div><p>Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity</p>
<div class="lb-trans"><p>股本回報率 = 淨利潤（來自持續經營）÷ 股東權益</p>
</div><p>So, based on the above formula, the ROE for Max Healthcare Institute is:</p>
<div class="lb-trans"><p>因此，根據上述公式，Max Healthcare Institute 的 ROE 為：</p>
</div><p>13% = ₹14b ÷ ₹101b (Based on the trailing twelve months to September 2025).</p>
<div class="lb-trans"><p>13% = ₹14b ÷ ₹101b（基於截至 2025 年 9 月的過去十二個月）。</p>
</div><p>The 'return' refers to a company's earnings over the last year. Another way to think of that is that for every ₹1 worth of equity, the company was able to earn ₹0.13 in profit.</p>
<div class="lb-trans"><p>“回報” 指的是公司在過去一年的收益。換句話説，對於每₹1 的股本，公司能夠賺取₹0.13 的利潤。</p>
</div><p>View our latest analysis for Max Healthcare Institute</p>
<div class="lb-trans"><p>查看我們對 Max Healthcare Institute 的最新分析</p>
</div><h2>What Has ROE Got To Do With Earnings Growth?</h2>
<div class="lb-trans"><h2>ROE 與盈利增長有什麼關係？</h2>
</div><p>We have already established that ROE serves as an efficient profit-generating gauge for a company's future earnings. Based on how much of its profits the company chooses to reinvest or &#34;retain&#34;, we are then able to evaluate a company's future ability to generate profits. Assuming all else is equal, companies that have both a higher return on equity and higher profit retention are usually the ones that have a higher growth rate when compared to companies that don't have the same features.</p>
<div class="lb-trans"><p>我們已經確定 ROE 作為公司未來盈利的有效利潤生成指標。根據公司選擇再投資或 “保留” 的利潤比例，我們能夠評估公司未來產生利潤的能力。假設其他條件相同，具有更高股本回報率和更高利潤保留的公司通常與沒有相同特徵的公司相比，具有更高的增長率。</p>
</div><h2>A Side By Side comparison of Max Healthcare Institute's Earnings Growth And 13% ROE</h2>
<div class="lb-trans"><h2>Max Healthcare Institute 的盈利增長與 13% ROE 的並排比較</h2>
</div><p>When you first look at it, Max Healthcare Institute's ROE doesn't look that attractive. However, the fact that the company's ROE is higher than the average industry ROE of 11%, is definitely interesting. Especially when you consider Max Healthcare Institute's exceptional 33% net income growth over the past five years. That being said, the company does have a slightly low ROE to begin with, just that it is higher than the industry average. So, there might well be other reasons for the earnings to grow. Such as- high earnings retention or the company belonging to a high growth industry.</p>
<div class="lb-trans"><p>乍一看，Max Healthcare Institute 的 ROE 似乎並不那麼吸引人。然而，值得注意的是，該公司的 ROE 高於行業平均 ROE 的 11%。尤其是考慮到 Max Healthcare Institute 在過去五年中實現了 33% 的淨收入增長。這意味着該公司的 ROE 雖然起初略低，但仍高於行業平均水平。因此，盈利增長可能還有其他原因，比如高盈利保留率或公司屬於高增長行業。</p>
</div><p>Next, on comparing with the industry net income growth, we found that Max Healthcare Institute's growth is quite high when compared to the industry average growth of 25% in the same period, which is great to see.</p>
<div class="lb-trans"><p>接下來，與行業淨收入增長進行比較，我們發現 Max Healthcare Institute 的增長在同一時期內相較於行業平均增長 25% 相當高，這令人欣慰。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/22615821-past-earnings-growth-1-dark-2/1767495947130" alt="" original-src="https://images.simplywall.st/asset/chart/22615821-past-earnings-growth-1-dark-2/1767495947130"/></p>
<p>NSEI:MAXHEALTH Past Earnings Growth January 4th 2026</p>
<div class="lb-trans"><p>NSEI:MAXHEALTH 過去的盈利增長 2026 年 1 月 4 日</p>
</div><p>Earnings growth is a huge factor in stock valuation. What investors need to determine next is if the expected earnings growth, or the lack of it, is already built into the share price. By doing so, they will have an idea if the stock is headed into clear blue waters or if swampy waters await. If you're wondering about Max Healthcare Institute's's valuation, check out this gauge of its price-to-earnings ratio, as compared to its industry.</p>
<div class="lb-trans"><p>盈利增長是股票估值的一個重要因素。投資者接下來需要確定預期的盈利增長或缺乏盈利增長是否已經反映在股價中。通過這樣做，他們將能夠判斷股票是朝着清澈的水域前進，還是等待着泥濘的水域。如果你對 Max Healthcare Institute 的估值感到好奇，可以查看其市盈率與行業的比較。</p>
</div><h2>Is Max Healthcare Institute Making Efficient Use Of Its Profits?</h2>
<div class="lb-trans"><h2>Max Healthcare Institute 是否有效利用其利潤？</h2>
</div><p>Max Healthcare Institute's ' three-year median payout ratio is on the lower side at 14% implying that it is retaining a higher percentage (86%) of its profits. This suggests that the management is reinvesting most of the profits to grow the business as evidenced by the growth seen by the company.</p>
<div class="lb-trans"><p>Max Healthcare Institute 的三年中位數派息比率較低，為 14%，這意味着它保留了更高比例（86%）的利潤。這表明管理層正在將大部分利潤再投資於業務增長，這從公司的增長中得到了證明。</p>
</div><p>While Max Healthcare Institute has seen growth in its earnings, it only recently started to pay a dividend. It is most likely that the company decided to impress new and existing shareholders with a dividend. Existing analyst estimates suggest that the company's future payout ratio is expected to drop to 8.1% over the next three years. The fact that the company's ROE is expected to rise to 18% over the same period is explained by the drop in the payout ratio.</p>
<div class="lb-trans"><p>儘管 Max Healthcare Institute 的盈利有所增長，但它最近才開始支付股息。公司很可能是為了給新老股東留下深刻印象而決定支付股息。現有分析師的估計表明，該公司的未來派息比率預計將在未來三年內降至 8.1%。與此同時，該公司的 ROE 預計將在同一時期內上升至 18%，這與派息比率的下降有關。</p>
</div><h2>Summary</h2>
<div class="lb-trans"><h2>總結</h2>
</div><p>Overall, we are quite pleased with Max Healthcare Institute's performance. In particular, it's great to see that the company has seen significant growth in its earnings backed by a respectable ROE and a high reinvestment rate. With that said, the latest industry analyst forecasts reveal that the company's earnings growth is expected to slow down. To know more about the company's future earnings growth forecasts take a look at this <strong>free</strong> report on analyst forecasts for the company to find out more.</p>
<div class="lb-trans"><p>總體而言，我們對 Max Healthcare Institute 的表現感到相當滿意。特別是看到公司在可觀的 ROE 和高再投資率的支持下實現了顯著的盈利增長，這令人振奮。儘管如此，最新的行業分析師預測顯示，該公司的盈利增長預計將放緩。要了解更多關於公司未來盈利增長預測的信息，請查看這份關於公司分析師預測的 <strong>免費</strong> 報告。</p>
</div><p>Mobile Infrastructure for Defense and Disaster</p>
<div class="lb-trans"><p>用於國防和災難的移動基礎設施</p>
</div><p>The next wave in robotics isn't humanoid. Its fully autonomous towers delivering 5G, ISR, and radar in under 30 minutes, anywhere.</p>
<div class="lb-trans"><p>下一波機器人技術不是類人型的。它是完全自主的塔，在 30 分鐘內提供 5G、ISR 和雷達，隨時隨地。</p>
</div><p>Get the investor briefing before the next round of contracts</p>
<div class="lb-trans"><p>在下一輪合同之前獲取投資者簡報</p>
</div><p>Sponsored On Behalf of CiTech</p>
<div class="lb-trans"><p>由 CiTech 贊助</p>
</div>

Max Healthcare Institute Limited (NSE:MAXHEALTH) 股票的疲軟是否表明市場在其強勁的財務前景下可能判斷失誤？